Pharma giant GSK PLC said Tuesday that it has agreed to acquire cancer therapy specialist Nuvalent Inc. for $10.6 billion as it seeks to accelerate its "rapid expansion" into the oncology market.
Nonprofit health system Ascension Health Alliance must divest several of its surgery center facilities in order to complete its proposed $3.9 billion acquisition of AmSurg LLC, the Federal Trade Commission said Tuesday.
Eli Lilly and Co. said Tuesday it will buy three companies involved in vaccine development — Curevo Inc., LimmaTech Biologics AG, and Vaccine Company Inc. — for a total of up to roughly $3.83 billion.
Previous
Next
Pharma giant GSK PLC said Tuesday that it has agreed to acquire cancer therapy specialist Nuvalent Inc. for $10.6 billion as it seeks to accelerate its "rapid expansion" into the oncology market.
Nonprofit health system Ascension Health Alliance must divest several of its surgery center facilities in order to complete its proposed $3.9 billion acquisition of AmSurg LLC, the Federal Trade Commission said Tuesday.
Eli Lilly and Co. said Tuesday it will buy three companies involved in vaccine development — Curevo Inc., LimmaTech Biologics AG, and Vaccine Company Inc. — for a total of up to roughly $3.83 billion.
-
June 09, 2026
McKesson locked horns Tuesday in New Jersey bankruptcy court with a trust created by Rite Aid's first Chapter 11 plan over whether the medication supplier must hand over antitrust claims against pharmaceutical companies.
-
June 09, 2026
Medical technology provider Novanta Inc., advised by Ropes & Gray LLP and King & Spalding LLP, on Tuesday announced plans to acquire medical device maker Riverpoint Medical, led by Goodwin Procter LLP, from private equity shop Arlington Capital Partners in a deal worth up to $1.45 billion.
-
June 09, 2026
The race to build the legal industry's largest law firm accelerated in 2025, with major firms leaning on mergers, lateral hiring and strategic expansion to climb the ranks of the Law360 400.
-
June 05, 2026
Texas' bankrupt former hospital owner Sherman/Grayson Hospital LLC said that professional fees have been paid, monthly operating reports filed and other steps taken that should prevent its Chapter 11 case from being converted to a Chapter 7 liquidation.
-
June 05, 2026
Nexus Pharmaceuticals lost its appeal of an Illinois federal judge's finding that it infringed a pair of patents relating to a line of injections that treat infections, after the Federal Circuit on Friday shot down the drugmaker's challenge to the lower court's interpretation of key patent terms.
-
June 04, 2026
The U.S. Government Accountability Office said Thursday that the U.S. Department of Defense's health agency hasn't sufficiently kept track of DOD partnerships with civilian medical facilities, thus impairing its ability to evaluate those partnerships and further reduce costs.
-
June 02, 2026
A first-of-its-kind halt on new Medicare enrollment for hospice and home health providers is shaking up dealmaking in the growing industry. A tougher enforcement landscape calls for more diligence from buyers and sellers, and renewed efforts to avoid what is known as the 36-month rule.
-
June 01, 2026
The North Carolina Business Court rounded out May by appointing a discovery referee in a healthcare antitrust class action and ordering the deposition of a top executive in a trade secrets battle, in addition to fielding a new complaint alleging unpaid capital contributions for a captive insurance company.
-
May 29, 2026
In this week's Taxation With Representation, Fertitta Entertainment acquires Caesars Entertainment, Eli Lilly and Co. buys three companies involved in vaccine development, and nuclear energy company Newcleo Ltd. says it plans to go public by merging with a special purpose acquisition company, NewHold Investment Corp. III.
-
May 28, 2026
Psychiatric hospital operator Oglethorpe Inc. has agreed to pay $32 million and be excluded from all federal healthcare programs for 10 years to resolve allegations it knowingly failed to return Medicare overpayments in violation of the False Claims Act.
-
May 28, 2026
Healthcare-focused private equity firm Ampersand Capital Partners, advised by McDermott Will & Schulte, on Thursday revealed that it closed its latest fund with $1.5 billion.
-
May 28, 2026
A Massachusetts federal jury on Thursday cleared a Johnson & Johnson MedTech subsidiary of allegations that it infringed a blood pump patent owned by a unit of Swedish medical device company Getinge AB.
-
May 28, 2026
A split Federal Circuit panel on Thursday erased Insulet Corp.'s trade secret victory against EOFlow Co. Ltd., holding that the medical device maker filed its claims too late and reversing a $452 million jury verdict that was later reduced to $59.4 million.
-
May 27, 2026
The former chief revenue officer of medical professional networking platform Doximity Inc. has been sentenced by a New York federal judge to just over two years in prison for securities fraud related to his trading on inside information before the company's earnings calls, prosecutors announced Wednesday.
-
May 27, 2026
Humana Inc. is in hot water with an investor following its inability to shake off a False Claims Act suit brought by the U.S. Department of Justice, with a stockholder suit filed in Kentucky on Wednesday saying the insurer's actions have exposed the company to "significant legal and financial risk."
-
May 26, 2026
A series of complaints lodged against health giant CVS may be a bellwether for more scrutiny to come against healthcare middlemen.
-
May 26, 2026
A former partner with Panza Maurer & Maynard has moved her administrative and regulatory and healthcare law practice to Stearns Weaver Miller Weissler Alhadeff & Sitterson PA in Tallahassee.
-
May 22, 2026
This past year, 10 lawyers across the country at plaintiffs' firms big and small helped secure millions of dollars in settlements and verdicts for their clients, going up against powerful defendants like Google, Monsanto and the Trump administration, earning the attorneys recognition as Law360's Titans of the Plaintiffs Bar for 2026.
-
May 20, 2026
Intellia Therapeutics Inc. has agreed to drop a set of claims it asserted in a Delaware federal suit brought by BlueAllele, which accused it of infringing three gene-editing patents to bring in $100 million in a deal with Regeneron Pharmaceuticals.
-
May 19, 2026
As the pharmaceutical industry grapples with the U.S. Supreme Court's refusal to hear about the legality of Medicare drug pricing negotiations, experts say to expect a pivot in and outside the courtrooms.
-
May 19, 2026
The Federal Circuit on Tuesday reinstated a pair of patent infringement suits from patent owners that licensed their intellectual property to other parties, finding that the companies met the minimum constitutional requirements to show they had standing to sue.
-
May 14, 2026
Takeda Pharmaceuticals will pay $13.6 million to end allegations that it caused false Medicaid claims by providing kickbacks to healthcare providers to push prescriptions of its antidepressant drug Trintellix, the U.S. Department of Justice announced Thursday.
-
May 14, 2026
Medical device maker Integer Holdings Corp.'s former CEO overstated growth prospects of a manufacturing program for the company's electrophysiology business, inflating the firm's stock price and allowing him to reap a nearly $39 million "windfall net profit," according to an investor's derivative lawsuit in Texas federal court.
-
May 14, 2026
Drug buyers urged a Massachusetts federal jury on Thursday to find that Takeda Pharmaceuticals conspired with another drugmaker to keep a generic version of anticonstipation drug Amitiza off the market in order to boost its own profits.
-
May 12, 2026
The healthcare industry wrapped up its first-quarter earnings readouts this week, closing off the season with major names like Novo Nordisk and CVS.